- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Victoria Plumbing Group Annual Revenue Rises 5%; Stock Up | ||
| Di | LondonMetric Property Expects 14% Rise In H1 Rental Income | ||
| Di | Ironveld Inks Multi-Year Mining Operations Deal With Daemaneng Minerals For Lapon Site | ||
| Di | MaaT Pharma's MaaT033 For Allo-HSCT Patients Clears Second DSMB Safety Review In Phase 2b Trial | ||
| Di | Akastor's AKOFS Offshore Secures $246 Mln Petrobras Contract For AKOFS Santos Vessel In Brazil | ||
| Di | AZN: Baxdrostat Meets Primary Endpoint In Phase III Trial For Treatment-Resistant Hypertension | ||
| Di | Oxford Biomedica Acquires $4.5 Mln North Carolina Gene Therapy Facility | ||
| Di | Veidekke Wins SEK 117 Mln Contract To Build Cultural Centre In Märsta, Sweden | ||
| Di | Qualtrics To Acquire Press Ganey Forsta For $6.75 Bln | ||
| Di | Coty Prices $900.0 Mln Of 5.600% Senior Notes Due 2031 | ||
| Mo | AMD Stock Soars Over 26% After Announcing AI Infrastructure Deal With OpenAI | ||
| Mo | Comerica Shares Jump 14% On $10.9 Bln Merger Deal With Fifth Third Bancorp | ||
| Mo | Tesla Stock Rises Over 4% On Hints Of New Product Unveiling | ||
| Mo | Paramount Acquires The Free Press, Appoints Bari Weiss As CBS News Editor-in-Chief | ||
| Mo | Vertiv Chief Technology Officer Stephen Liang To Retire | ||
| Mo | Daré Bioscience Receives $4 Mln Grant Funding For Smart Contraceptive Program | ||
| Mo | Barrick Mining To Sell Tongon Gold Mine And Exploration Assets To Atlantic Group For Up To $305 Mln | ||
| Mo | Kolibri Global Energy Reports Revised Guidance For FY2025 | ||
| Mo | Abacus Global Management Acquires AccuQuote | ||
| Mo | Precision Drilling Promotes Carey Ford To Succeed Kevin Neveu As President And CEO | ||
| Mo | Toro To Acquire Tornado Infrastructure Equipment | ||
| Mo | Phathom Pharmaceuticals Appoints Sanjeev Narula As Chief Financial And Business Officer | ||
| Mo | Stoke Therapeutics Names Ian Smith As CEO; Phase 3 Trial Of Zorevunersen Underway | ||
| Mo | Invivyd Gets FDA Clearance To Start Clinical Trials For COVID-19 Antibody VYD2311 | ||
| Mo | Skye Says CBeyond Phase 2a Study Of Nimacimab Monotherapy Did Not Meet Primary Endpoint |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .